1. Home
  2. VTS vs VIR Comparison

VTS vs VIR Comparison

Compare VTS & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vitesse Energy Inc.

VTS

Vitesse Energy Inc.

HOLD

Current Price

$19.24

Market Cap

817.2M

Sector

Energy

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.11

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTS
VIR
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
817.2M
825.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
VTS
VIR
Price
$19.24
$6.11
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$28.00
$25.73
AVG Volume (30 Days)
431.3K
2.0M
Earning Date
11-03-2025
11-05-2025
Dividend Yield
11.69%
N/A
EPS Growth
N/A
N/A
EPS
0.56
N/A
Revenue
$248,169,000.00
$16,860,000.00
Revenue This Year
$29.38
N/A
Revenue Next Year
N/A
$46.25
P/E Ratio
$34.52
N/A
Revenue Growth
6.73
N/A
52 Week Low
$18.86
$4.16
52 Week High
$27.49
$14.45

Technical Indicators

Market Signals
Indicator
VTS
VIR
Relative Strength Index (RSI) 28.59 49.41
Support Level $20.12 $5.73
Resistance Level $20.81 $6.11
Average True Range (ATR) 0.57 0.39
MACD -0.23 -0.08
Stochastic Oscillator 10.86 28.57

Price Performance

Historical Comparison
VTS
VIR

About VTS Vitesse Energy Inc.

Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: